Drug & intervention

ethionamide

RxCUI 4127

Clinical trials1
Recruiting0
Related conditions2
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Ethionamide

Ethionamide (ETA or ETH) is an antibiotic used to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, to treat active multidrug-resistant tuberculosis. It is no longer recommended for leprosy. It is taken by mouth. Ethionamide has a high rate of side effects. Common side effects include nausea, diarrhea, abdominal pain, and loss of appetite. Serious side effects may include liver inflammation and depression. It should not be used in people with significant liver problems. Use in pregnancy is not recommended as safety is unclear. Ethionamide is in the thioamides family of medications. It is believed to work by interfering with the use of mycolic acid. Ethionamide was discovered in 1956 and approved for medical use in the United States in 1965. It is on the World Health Organization's List of Essential Medicines.

Read on Wikipedia ↗ Wikidata Q414767 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.